Reaction
Tumour Invasion reporting signals
As of the last recalculation, Tumour Invasion appears in 472 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is POLATUZUMAB VEDOTIN (PRR 32.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Polatuzumab Vedotin | 7 | 32.1 | 32.1 |
| Sitagliptin And Metformin Hydrochloride | 15 | 31.6 | 31.7 |
| Sorafenib | 11 | 23.9 | 23.9 |
| Dabrafenib | 11 | 23.5 | 23.6 |
| Axicabtagene Ciloleucel | 5 | 22.6 | 22.6 |
| Trametinib | 12 | 22.4 | 22.5 |
| Ado-Trastuzumab Emtansine | 4 | 21.1 | 21.1 |